MiR-2392 suppresses metastasis and epithelial- mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer
MiR-2392 suppresses metastasis and epithelial- mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer
复制标题
MiR-2392 通过靶向 MAML3 和 WHSC1 抑制胃癌的转移和上皮间质转化
DOI:
10.1096/fj.201601140rr
复制
发表时间:
2017-09-01
期刊:
影响因子:
4.8
通讯作者:
Fan, Daiming
中科院分区:
文献类型:
--
作者:
Li, Jinjing;Li, Tingyu;Fan, Daiming
MicroRNAs have emerged as essential regulators of various cellular processes. We identified the role and underlying mechanisms of miR-2392 in gastric cancer (GC) metastasis. MiR-2392 was down-regulated in GC cell lines and tissues, and overexpression of miR-2392 significantly inhibited GC invasion and metastasis in vitro and in vivo. We identified MAML3 and WHSC1 as novel targets of miR-2392, and knockdown of MAML3 and WHSC1 had the same antimetastatic effect as that of miR-2392 in GC cells. These effects were clinically relevant, as low miR-2392 expression was correlated with high MAML3 and WHSC1 expression and poor survival in patients with GC. Furthermore, forced expression of miR-2392 substantially suppressed Slug and Twist1, transcriptional repressors of E-cadherin, by targeting MAML3 and WHSC1, respectively, resulting in inhibition of the epithelial-mesenchymal transition. These findings indicate that the miR-2392-MAML3/WHSC1-Slug/Twist1 regulatory axis plays a critical role in GC metastasis. Restoration of miR-2392 may be a therapeutic approach for blocking GC metastasis.